Teijin Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Die Gewinne von Teijin sind mit einer durchschnittlichen Jahresrate von -59.1% zurückgegangen, während die Gewinne der Branche Chemicals um 5.4% pro Jahr wuchsen. Die Umsätze sind gewachsen mit einer durchschnittlichen Jahresrate von 1.7%.
Wichtige Informationen
-59.12%
Wachstumsrate der Gewinne
-59.07%
EPS-Wachstumsrate
| Chemicals Wachstum der Industrie | 6.58% |
| Wachstumsrate der Einnahmen | 1.67% |
| Eigenkapitalrendite | -23.85% |
| Netto-Marge | -10.08% |
| Letzte Ertragsaktualisierung | 31 Mar 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Narrativ-Update • May 25
3401: Deepening Loss Guidance And Impairments Will Sustain Weak Earnings And Overvaluation
Analysts have held Teijin's fair value estimate steady at ¥1,368. The updated price target reflects revised assumptions around a 7.0% discount rate, revenue growth of about 2.21%, a profit margin of roughly 2.14%, and a future P/E of about 16.22x.Narrativ-Update • May 02
3401: Deepening Loss Guidance Will Still Signal Weak Earnings And Overvaluation
Analysts kept their price target for Teijin steady at ¥1,368, citing only slight model tweaks in the discount rate, revenue growth, profit margin and future P/E assumptions that do not materially change their view of the shares. What's in the News Teijin cut its consolidated earnings guidance for the fiscal year ending March 31, 2026, and now expects an operating loss of JPY 75,000 million to JPY 85,000 million instead of the previously guided operating income of JPY 5,000 million (Key Developments).Narrativ-Update • Apr 14
3401: Deepening Loss Outlook Will Still Signal Weak Earnings And Overvaluation
Analysts have revised their price target on Teijin to ¥1,368 from ¥1,328. The new target reflects updated assumptions for revenue growth, profit margins, the discount rate and future P/E multiples.Narrativ-Update • Mar 31
3401: Stable Assumptions Will Still Signal Weak Earnings And Overvaluation
Analysts have kept their ¥1,328 price target for Teijin unchanged, citing only minor model adjustments to discount rate, revenue growth, profit margin and future P/E assumptions that do not materially alter their view on the shares. Valuation Changes Fair Value: Modelled fair value remains unchanged at ¥1,328.Narrativ-Update • Mar 17
3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook
Narrative Update on Teijin The analyst fair value estimate for Teijin has been revised from ¥1,298 to ¥1,328, with analysts linking this change to updated assumptions for revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value: Revised slightly higher from ¥1,298 to ¥1,328.Narrativ-Update • Mar 03
3401: Higher P/E Assumptions Will Still Signal Weak Earnings Outlook
Analysts have raised their price target for Teijin from ¥1,256 to ¥1,298, reflecting slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E. Valuation Changes Fair Value: revised from ¥1,256 to ¥1,298, a modest uplift in the model output.Narrativ-Update • Feb 16
3401: Modest Margin Gains And Merger Plans Will Still Signal Weak Outlook
Analysts have kept their ¥1,256 price target for Teijin unchanged, citing a slightly lower discount rate, an expected shift from a 1.66% revenue decline to a 0.21% revenue increase, a modest uptick in profit margin, and a reduced assumed future P/E as key factors supporting their maintained view. What's in the News A board meeting is scheduled for December 1, 2025, to consider a basic agreement for an absorption-type merger between Teijin Frontier Co., Ltd., a wholly owned Teijin subsidiary, and Asahi Kasei Advance Corporation, a wholly owned Asahi Kasei subsidiary, with Teijin Frontier as the surviving company (Key Developments).Narrativ-Update • Feb 02
3401: Aramid Impairment Will Drive Weaker Outlook Despite Merger Plans
Analysts have maintained their fair value estimate for Teijin at ¥1,256. A slightly lower discount rate and a marginally reduced future P/E assumption support a modestly refined price target narrative.Narrativ-Update • Jan 19
3401: Aramid Impairment Will Drive Cautious Outlook Despite Merger Plans
Analysts have nudged their fair value estimate for Teijin up from ¥1,246 to ¥1,256, citing slightly softer assumed revenue declines, a modestly lower discount rate, and a small adjustment to future P/E expectations as the key drivers of the change. What's in the News Teijin plans a board meeting on December 1, 2025 to consider a basic agreement for an absorption type merger between Teijin Frontier Co., Ltd.Narrativ-Update • Jan 05
3401: Aramid Impairment And Joint Venture Integration Will Shape Balanced Outlook
Analysts kept their fair value estimate for Teijin steady at ¥1,246, with only small tweaks to the discount rate, long term revenue and margin assumptions, and the future P/E used in their models. This reflects fine tuning rather than a change in their overall view.Narrativ-Update • Dec 21
3401: Aramid Impairment And Joint Venture Integration Will Define Balanced Outlook
Analysts have nudged their price target on Teijin modestly higher to ¥1,246. This reflects slightly lower perceived risk and a marginally cheaper forward earnings multiple, even as growth and margin assumptions remain essentially unchanged.Analyseartikel • Dec 19
Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00
Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥25.00 per share on the 4th of June. Based on...Narrativ-Update • Dec 07
3401: Aramid Impairment And Earnings Resilience Will Shape Balanced Forward Prospects
Analysts have nudged their price target on Teijin slightly higher to JPY 1,246, citing a modestly lower perceived risk profile and stable long term earnings assumptions, despite limited changes to underlying growth and margin forecasts. What's in the News Board meeting scheduled for December 1, 2025, to approve a basic agreement for an absorption type merger between Teijin Frontier and Asahi Kasei Advance, with Teijin Frontier as the surviving company and later becoming a joint venture of Teijin and Asahi Kasei (company disclosure) Resin and plastic processing business briefing session held for analysts and investors, focusing on the outlook and strategy for this segment (company event) Impairment loss of JPY 48.4 billion recorded on fixed assets in the aramid business for the six months ended September 30, 2025, driven by intensifying competition and adverse exchange rate movements, with charges booked in cost of sales and SG&A (company results) Full-year 2025 to 2026 earnings guidance revised downward, with operating income forecast cut from JPY 20 billion to JPY 5 billion and profit attributable to owners of parent now expected to be a loss of JPY 10 billion, mainly due to the aramid impairment and weaker materials and equity method contributions (guidance update) Valuation Changes Fair Value: unchanged at approximately ¥1,246 per share, implying no revision to the analyst central valuation.Analyseartikel • Dec 05
Teijin's (TSE:3401) Dividend Will Be ¥25.00
Teijin Limited ( TSE:3401 ) will pay a dividend of ¥25.00 on the 4th of June. Based on this payment, the dividend yield...Narrativ-Update • Nov 23
3401: Impairment Loss And Margin Stability Will Define Balanced Investment Prospects
The analyst price target for Teijin has been reaffirmed at ¥1,246 as analysts cite stable forecasts and no material changes in forecasts for discount rate, revenue growth, profit margin, or projected valuation multiples. What's in the News Teijin held a Resin & Plastic Processing Business Briefing Session as part of their Analyst/Investor Day.Narrativ-Update • Nov 08
3401: Revenue Outlook Will Moderate Risks While Supporting Balanced Opportunity
Analysts have raised their price target for Teijin from ¥1,180 to ¥1,246. This reflects an improved revenue growth outlook and a lower discount rate in updated forecasts.Neues Narrativ • Sep 07
Global Demand For Advanced Composites Will Expand Opportunities
Key Takeaways Refocus on high-margin specialty materials and healthcare segments, combined with operational reforms, is expected to drive margin expansion and more stable earnings. Innovation in sustainable materials and divestment of low-yield businesses position the company for new growth opportunities and improved earnings quality.Analyseartikel • Jul 24
Teijin (TSE:3401) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Apr 14
Are Investors Undervaluing Teijin Limited (TSE:3401) By 45%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Teijin fair value estimate is JP¥2,032 Teijin's JP¥1,127 share...Analyseartikel • Mar 22
Teijin (TSE:3401) Will Pay A Dividend Of ¥25.00
The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend on the 30th of May, with investors...Analyseartikel • Feb 03
Is Teijin (TSE:3401) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Dec 31
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00
Teijin Limited ( TSE:3401 ) will pay a dividend of ¥25.00 on the 30th of May. This takes the dividend yield to 3.7...Analyseartikel • Dec 17
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥25.00
The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥25.00 per share on the 30th of...Analyseartikel • Dec 03
Teijin (TSE:3401) Has Announced A Dividend Of ¥25.00
Teijin Limited's ( TSE:3401 ) investors are due to receive a payment of ¥25.00 per share on 30th of May. This will take...Analyseartikel • Dec 01
Is There An Opportunity With Teijin Limited's (TSE:3401) 46% Undervaluation?
Key Insights Teijin's estimated fair value is JP¥2,422 based on 2 Stage Free Cash Flow to Equity Teijin is estimated to...Analyseartikel • Nov 07
Some Confidence Is Lacking In Teijin Limited's (TSE:3401) P/S
With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Chemicals industry in Japan, you could be...Analyseartikel • Oct 17
Be Wary Of Teijin (TSE:3401) And Its Returns On Capital
When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...Analyseartikel • Sep 18
Teijin (TSE:3401) Has A Somewhat Strained Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Aug 04
Investor Optimism Abounds Teijin Limited (TSE:3401) But Growth Is Lacking
With a median price-to-sales (or "P/S") ratio of close to 0.5x in the Chemicals industry in Japan, you could be...Analyseartikel • Jun 10
A Look At The Fair Value Of Teijin Limited (TSE:3401)
Key Insights Teijin's estimated fair value is JP¥1,442 based on 2 Stage Free Cash Flow to Equity Current share price of...Analyseartikel • May 21
There May Be Underlying Issues With The Quality Of Teijin's (TSE:3401) Earnings
Despite announcing strong earnings, Teijin Limited's ( TSE:3401 ) stock was sluggish. We did some digging and found...Analyseartikel • Apr 09
Teijin (TSE:3401) Will Be Looking To Turn Around Its Returns
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Analyseartikel • Mar 21
Teijin (TSE:3401) Will Pay A Dividend Of ¥15.00
The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥15.00 per share on the 31st of...Analyseartikel • Mar 16
Teijin Limited's (TSE:3401) Share Price Matching Investor Opinion
There wouldn't be many who think Teijin Limited's ( TSE:3401 ) price-to-sales (or "P/S") ratio of 0.3x is worth a...Analyseartikel • Feb 28
Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥15.00
The board of Teijin Limited ( TSE:3401 ) has announced that it will pay a dividend of ¥15.00 per share on the 31st of...Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Teijin Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 873,190 | -88,003 | 200,390 | 0 |
| 31 Dec 25 | 909,237 | -81,603 | 197,437 | 0 |
| 30 Sep 25 | 949,011 | -76,620 | 250,483 | 0 |
| 30 Jun 25 | 993,247 | -82,148 | 226,065 | 0 |
| 31 Mar 25 | 1,005,471 | -77,711 | 270,330 | 0 |
| 31 Dec 24 | 1,080,075 | -50,562 | 281,453 | 0 |
| 30 Sep 24 | 1,033,772 | -44,786 | 195,801 | 42,560 |
| 30 Jun 24 | 1,059,051 | 13,490 | 264,329 | 0 |
| 31 Mar 24 | 1,032,773 | 10,599 | 190,830 | 42,560 |
| 31 Dec 23 | 1,013,251 | -7,190 | 194,341 | 31,935 |
| 30 Sep 23 | 1,014,802 | -25,811 | 178,445 | 31,935 |
| 30 Jun 23 | 1,019,758 | -23,108 | 176,690 | 31,935 |
| 31 Mar 23 | 1,018,751 | -17,695 | 173,966 | 31,935 |
| 31 Dec 22 | 1,004,148 | -9,733 | 173,052 | 33,341 |
| 30 Sep 22 | 983,122 | 9,163 | 172,878 | 33,341 |
| 30 Jun 22 | 943,999 | 20,628 | 168,258 | 33,341 |
| 31 Mar 22 | 926,054 | 23,158 | 163,721 | 33,341 |
| 31 Dec 21 | 913,776 | -7,646 | 174,470 | 32,719 |
| 30 Sep 21 | 895,756 | -1,088 | 166,662 | 32,719 |
| 30 Jun 21 | 883,288 | -2,558 | 160,199 | 32,719 |
| 31 Mar 21 | 836,512 | -6,662 | 153,683 | 32,719 |
| 31 Dec 20 | 816,027 | 21,908 | 150,159 | 34,482 |
| 30 Sep 20 | 811,847 | 20,804 | 151,760 | 34,482 |
| 30 Jun 20 | 818,238 | 20,171 | 154,886 | 34,482 |
| 31 Mar 20 | 853,746 | 25,252 | 158,505 | 34,482 |
| 31 Dec 19 | 876,399 | 34,470 | 159,947 | 36,422 |
| 30 Sep 19 | 885,211 | 31,593 | 161,041 | 36,422 |
| 30 Jun 19 | 886,836 | 36,353 | 159,275 | 36,422 |
| 31 Mar 19 | 888,589 | 45,057 | 159,036 | 36,422 |
| 31 Dec 18 | 879,958 | 46,582 | 159,989 | 35,926 |
| 30 Sep 18 | 869,749 | 50,281 | 156,514 | 35,926 |
| 30 Jun 18 | 853,120 | 51,641 | 155,326 | 35,926 |
| 31 Mar 18 | 834,985 | 45,556 | 152,655 | 35,926 |
| 31 Dec 17 | 820,788 | 55,795 | 152,997 | 35,416 |
| 30 Sep 17 | 792,896 | 57,946 | 150,452 | 35,416 |
| 30 Jun 17 | 765,304 | 52,093 | 151,512 | 35,416 |
| 31 Mar 17 | 741,291 | 50,133 | 149,177 | 35,416 |
| 31 Dec 16 | 734,635 | 30,233 | 158,220 | 33,285 |
| 30 Sep 16 | 751,740 | 27,996 | 157,421 | 33,285 |
| 30 Jun 16 | 772,409 | 31,336 | 187,456 | 0 |
| 31 Mar 16 | 790,748 | 31,090 | 154,024 | 33,285 |
| 31 Dec 15 | 799,014 | 41,260 | 145,437 | 32,366 |
| 30 Sep 15 | 800,829 | 38,724 | 159,272 | 16,950 |
| 30 Jun 15 | 796,878 | 1,456 | 140,811 | 32,366 |
Qualität der Erträge: 3401 ist derzeit unrentabel.
Wachsende Gewinnspanne: 3401 ist derzeit unrentabel.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 3401 ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 59.1% pro Jahr zugenommen.
Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von 3401 verglichen werden, da das Unternehmen derzeit nicht profitabel ist.
Erträge im Vergleich zur Industrie: 3401 ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Chemicals (11%) erschwert.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 3401 hat eine negative Eigenkapitalrendite (-23.85%), da es derzeit unrentabel ist.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/01 09:40 |
| Aktienkurs zum Tagesende | 2026/06/01 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2026/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Teijin Limited wird von 17 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Mikiya Yamada | Barclays |
| Akiko Kuwahara | BofA Global Research |
| Atsushi Ikeda | Citigroup Inc |